Clinical Trials Browser

Phase 2 × flibanserin × 1 year × Clear all

NCT03707340 2025-11-04

A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

Phase 2 Active not recruiting

Breast Neoplasms

NCT04743934 2025-05-04

RAD 2003

Phase 2 Active not recruiting

Prostate Adenocarcinoma